Truleum Statistics
Total Valuation
Truleum has a market cap or net worth of 65.38 million. The enterprise value is 69.11 million.
| Market Cap | 65.38M |
| Enterprise Value | 69.11M |
Important Dates
The next estimated earnings date is Friday, April 4, 2025.
| Earnings Date | Apr 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Truleum has 21.79 million shares outstanding. The number of shares has increased by 5.99% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 21.79M |
| Shares Change (YoY) | +5.99% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 3.11% |
| Owned by Institutions (%) | n/a |
| Float | 5.22M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -29.99 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -57.10 |
Financial Position
The company has a current ratio of 0.02
| Current Ratio | 0.02 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.08 |
| Interest Coverage | -8.15 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -68.99% |
| Return on Capital (ROIC) | -182.56% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.33% in the last 52 weeks. The beta is -1.22, so Truleum's price volatility has been lower than the market average.
| Beta (5Y) | -1.22 |
| 52-Week Price Change | -33.33% |
| 50-Day Moving Average | 4.26 |
| 200-Day Moving Average | 5.36 |
| Relative Strength Index (RSI) | 47.65 |
| Average Volume (20 Days) | 546 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Truleum had revenue of 83,012 and -2.30 million in losses. Loss per share was -0.11.
| Revenue | 83,012 |
| Gross Profit | -185,041 |
| Operating Income | -2.05M |
| Pretax Income | -2.30M |
| Net Income | -2.30M |
| EBITDA | -1.99M |
| EBIT | -2.05M |
| Loss Per Share | -0.11 |
Balance Sheet
The company has 5,530 in cash and 3.73 million in debt, giving a net cash position of -3.72 million or -0.17 per share.
| Cash & Cash Equivalents | 5,530 |
| Total Debt | 3.73M |
| Net Cash | -3.72M |
| Net Cash Per Share | -0.17 |
| Equity (Book Value) | -3.02M |
| Book Value Per Share | -0.14 |
| Working Capital | -3.56M |
Cash Flow
In the last 12 months, operating cash flow was -928,646 and capital expenditures -281,623, giving a free cash flow of -1.21 million.
| Operating Cash Flow | -928,646 |
| Capital Expenditures | -281,623 |
| Free Cash Flow | -1.21M |
| FCF Per Share | -0.06 |
Margins
| Gross Margin | -222.91% |
| Operating Margin | -2,471.03% |
| Pretax Margin | -2,775.63% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Truleum does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.99% |
| Shareholder Yield | -5.99% |
| Earnings Yield | -3.53% |
| FCF Yield | -1.85% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Truleum has an Altman Z-Score of -1.02. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.02 |
| Piotroski F-Score | n/a |